Consolidated statement of changes in equity
- Homepage
- Financial Statements
- Consolidated statement of changes in equity
Contact
Fresenius SE & Co. KGaA
Investor Relations & Sustainability
+49 (0) 6172 608-2485
ir-fre@fresenius.comRelated Links
Share price
Data is delayed by 15 minutes.
Detailed chartLibrary
Download (XLSX, 47 KB)
Consolidated statement of changes in equity
| Subscribed Capital | Reserves | |||||
|---|---|---|---|---|---|---|
| Note | Number of ordinary shares in thousand | Amount € in thousands | Amount € in millions | Capital reserve € in millions | Other reserves € in millions | |
| As of December 31, 2018 | 556,225 | 556,225 | 556 | 3,933 | 11,252 | |
| Adjustment due to the initial application of IFRS 16 | 0 | 0 | 0 | 0 | -46 | |
| As of January 1, 2019, adjusted | 556,225 | 556,225 | 556 | 3,933 | 11,206 | |
| Proceeds from the exercise of stock options | 36 | 1,155 | 1,155 | 1 | 36 | |
| Compensation expense related to stock options | 36 | 20 | ||||
| Dividends paid | 28 | -445 | ||||
| Purchase of noncontrolling interests | 27 | |||||
| Share buy-back program of Fresenius Medical Care AG & Co. KGaA | -190 | |||||
| Put option liabilities | 22, 32 | -32 | ||||
| Comprehensive income (loss) | ||||||
| Net income | 1,883 | |||||
| Other comprehensive income (loss) | ||||||
| Cash flow hedges | 29, 32 | |||||
| Change of FVOCI equity investments | ||||||
| Foreign currency translation | 29, 32 | |||||
| Actuarial losses on defined benefit pension plans | 26, 29 | |||||
| Fair value changes | ||||||
| Comprehensive income (loss) | 1,883 | |||||
| As of December 31, 2019 | 557,380 | 557,380 | 557 | 3,989 | 12,422 | |
| Proceeds from the exercise of stock options | 36 | 161 | 161 | – | 9 | |
| Compensation expense related to stock options | 36 | -6 | ||||
| Dividends paid | 28 | -468 | ||||
| Purchase of noncontrolling interests | 27 | |||||
| Share buy-back program of Fresenius Medical Care AG & Co. KGaA | 28 | -118 | ||||
| Put option liabilities | 22, 32 | -8 | ||||
| Comprehensive income (loss) | ||||||
| Net income | 1,707 | |||||
| Other Comprehensive Income (Loss) | ||||||
| Cash flow hedges | 29, 32 | |||||
| Change of FVOCI equity investments | 29, 32 | |||||
| Foreign currency translation | 29, 32 | |||||
| Actuarial gains on defined benefit pension plans | 26, 29 | |||||
| Fair value changes | ||||||
| Comprehensive income (loss) | 1,707 | |||||
| As of December 31, 2020 | 557,541 | 557,541 | 557 | 3,992 | 13,535 | |
Download (XLSX, 47 KB)
Consolidated statement of changes in equity
| Accumulated other comprehensive income (loss) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Foreign currency translation € in millions | Cash flow hedges € in millions | Pensions € in millions | Equity investments € in millions | Fair value changes € in millions | Total Fresenius SE & Co. KGaA shareholders’ equity € in millions | Noncontrolling interests € in millions | Total shareholders’ equity € in millions | |
| As of December 31, 2018 | 38 | -61 | -311 | 4 | 0 | 15,411 | 9,597 | 25,008 |
| Adjustment due to the initial application of IFRS 16 | 0 | 0 | 0 | 0 | 0 | -46 | -98 | -144 |
| As of January 1, 2019, adjusted | 38 | -61 | -311 | 4 | 0 | 15,365 | 9,499 | 24,864 |
| Proceeds from the exercise of stock options | 37 | 11 | 48 | |||||
| Compensation expense related to stock options | 20 | 1 | 21 | |||||
| Dividends paid | -445 | -507 | -952 | |||||
| Purchase of noncontrolling interests | 0 | 40 | 40 | |||||
| Share buy-back program of Fresenius Medical Care AG & Co. KGaA | -190 | -410 | -600 | |||||
| Put option liabilities | -32 | -69 | -101 | |||||
| Comprehensive income (loss) | ||||||||
| Net income | 1,883 | 1,146 | 3,029 | |||||
| Other comprehensive income (loss) | ||||||||
| Cash flow hedges | -4 | -4 | -6 | -10 | ||||
| Change of FVOCI equity investments | 6 | 6 | 0 | 6 | ||||
| Foreign currency translation | 256 | -2 | 254 | 145 | 399 | |||
| Actuarial losses on defined benefit pension plans | -116 | -116 | -48 | -164 | ||||
| Fair value changes | 0 | 0 | 0 | |||||
| Comprehensive income (loss) | 256 | -4 | -118 | 6 | 0 | 2,023 | 1,237 | 3,260 |
| As of December 31, 2019 | 294 | -65 | -429 | 10 | 0 | 16,778 | 9,802 | 26,580 |
| Proceeds from the exercise of stock options | 9 | 9 | 18 | |||||
| Compensation expense related to stock options | -6 | - | -6 | |||||
| Dividends paid | -468 | -592 | -1,060 | |||||
| Purchase of noncontrolling interests | 0 | 28 | 28 | |||||
| Share buy-back program of Fresenius Medical Care AG & Co. KGaA | -118 | -248 | -366 | |||||
| Put option liabilities | -8 | -17 | -25 | |||||
| Comprehensive income (loss) | ||||||||
| Net income | 1,707 | 1,116 | 2,823 | |||||
| Other Comprehensive Income (Loss) | ||||||||
| Cash flow hedges | 3 | 3 | 1 | 4 | ||||
| Change of FVOCI equity investments | -1 | -1 | 4 | 3 | ||||
| Foreign currency translation | -998 | 5 | -993 | -1,087 | -2,080 | |||
| Actuarial gains on defined benefit pension plans | 19 | 19 | 2 | 21 | ||||
| Fair value changes | 27 | 27 | 56 | 83 | ||||
| Comprehensive income (loss) | -998 | 3 | 24 | -1 | 27 | 762 | 92 | 854 |
| As of December 31, 2020 | -704 | -62 | -405 | 9 | 27 | 16,949 | 9,074 | 26,023 |
| The following notes are an integral part of the consolidated financial statements. | ||||||||
Contact us
Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-2294
pr-fre@fresenius.com
Consolidated statement of cash flows
Consolidated segment reporting